CHRONIC SPONTANEOUS URTICARIA
Clinical trials for CHRONIC SPONTANEOUS URTICARIA explained in plain language.
Never miss a new study
Get alerted when new CHRONIC SPONTANEOUS URTICARIA trials appear
Sign up with your email to follow new studies for CHRONIC SPONTANEOUS URTICARIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with uncontrollable hives
Disease control CompletedThis study tested the drug dupilumab in children aged 2 to 12 with chronic spontaneous urticaria (CSU), a condition causing long-lasting, itchy hives. The goal was to see how the drug behaves in the body and check its safety in children whose hives were not controlled by standard…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug shows promise for controlling chronic hives
Disease control CompletedThis study tested whether a new oral medication called povorcitinib could help adults with chronic spontaneous urticaria (CSU), a condition causing persistent hives and itching that doesn't respond well to standard antihistamines. Researchers compared different doses of the drug …
Matched conditions: CHRONIC SPONTANEOUS URTICARIA
Phase: PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
New injection tested to tame Teenagers' unexplained hives
Disease control CompletedThis study tested an injectable drug called ligelizumab to see if it could better control chronic, unexplained hives in teenagers. It involved 49 adolescents aged 12 to 18 who still had bothersome hives despite taking standard allergy pills. Participants received either a high do…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
New hives drug put to blood pressure test
Disease control CompletedThis study checked if a new drug called remibrutinib affects blood pressure in adults with chronic hives that standard allergy pills don't control. For 12 weeks, 144 participants took the drug while wearing a portable blood pressure monitor. The main goal was to see if the drug c…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New hope for teens with uncontrollable hives
Disease control CompletedThis study looked at the safety and real-world effectiveness of an injectable medication called Xolair (omalizumab) for Chinese teenagers with chronic spontaneous urticaria (CSU), a condition causing persistent, itchy hives. It involved 55 adolescents whose hives were not adequat…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New injection tested for people whose hives Won't quit
Disease control CompletedThis study tested an investigational injection called LP-003 for adults with chronic spontaneous urticaria (CSU), a condition causing long-lasting, itchy hives. It was for people whose hives and itching were not controlled even with standard or higher doses of common antihistamin…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA
Phase: PHASE2 • Sponsor: Longbio Pharma • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
First human test for new hives drug candidate begins
Knowledge-focused CompletedThis was the first study in humans to test a potential new drug called LP-003, which is being developed for chronic hives. Researchers gave single and then multiple doses to 60 healthy volunteers to check if it was safe and to see how the body processes it. The main goal was to u…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA
Phase: PHASE1 • Sponsor: Longbio Pharma • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC